U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H21N3O2.ClH
Molecular Weight 371.861
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TUBASTATIN A HYDROCHLORIDE

SMILES

Cl.CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO

InChI

InChIKey=LJTSJTWIMOGKRJ-UHFFFAOYSA-N
InChI=1S/C20H21N3O2.ClH/c1-22-11-10-19-17(13-22)16-4-2-3-5-18(16)23(19)12-14-6-8-15(9-7-14)20(24)21-25;/h2-9,25H,10-13H2,1H3,(H,21,24);1H

HIDE SMILES / InChI

Molecular Formula C20H21N3O2
Molecular Weight 335.3996
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/26086931 | https://www.ncbi.nlm.nih.gov/pubmed/25637120 | https://www.ncbi.nlm.nih.gov/pubmed/23964961 | https://www.ncbi.nlm.nih.gov/pubmed/20614936 | https://www.ncbi.nlm.nih.gov/pubmed/28131906

Tubastatin A is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay. Tubastatin A is a very selective HDAC6 inhibitor with 100 to over 1000-fold selectivity for HDAC6 over other HDAC classes. Tubastatin A increases the total numbers of mitochondria and restores the number of moving mitochondria in DRG neurons. It reverses the axonal loss in peripheral neurons in the mouse model of Charcot-Marie-Tooth disease. Tubastatin A inhibits the deacetylation of α-tubulin in murine myoblasts.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
15.0 nM [IC50]
854.0 nM [IC50]
16400.0 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
A novel HDAC6 inhibitor Tubastatin A: Controls HDAC6-p97/VCP-mediated ubiquitination-autophagy turnover and reverses Temozolomide-induced ER stress-tolerance in GBM cells.
2017 Apr 10
Patents

Patents

Sample Use Guides

rTg4510 mice were used for activity evaluation. Tubastatin A was administered using daily intraperitoneal injections into rTg4510 mice and nontransgenic littermates from 5 to 7 months of age. Each group consisted of six animals per genotype. Mice were weighed, and injected with tubastatin (25 mg/kg) or 0.9% normal saline solution (vehicle).
Route of Administration: Intraperitoneal
TUB (Tubastatin A) enhanced TMZ (Temozolomide)-induced cytotoxicity in different TMZ-resistant cell lines (A172, U118, U251, U87). Cells were pre-incubated with TUB (1-32 mkM) for 12 h and then co-treated with 34mkM of TMZ for 24 h. Cell viability rates were determined by a CCK-8 assay.
Substance Class Chemical
Created
by admin
on Sat Dec 16 13:25:39 GMT 2023
Edited
by admin
on Sat Dec 16 13:25:39 GMT 2023
Record UNII
UHCM2AYJVX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TUBASTATIN A HYDROCHLORIDE
Common Name English
TUBASTATIN A HCL
Common Name English
4-((2-METHYL-3,4-DIHYDRO-1H-PYRIDO(4,3-B)INDOL-5-YL)METHYL)BENZENECARBOHYDROXAMIC ACID HYDROCHLORIDE
Systematic Name English
BENZAMIDE, N-HYDROXY-4-((1,2,3,4-TETRAHYDRO-2-METHYL-5H-PYRIDO(4,3-B)INDOL-5-YL)METHYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
PUBCHEM
57336514
Created by admin on Sat Dec 16 13:25:39 GMT 2023 , Edited by admin on Sat Dec 16 13:25:39 GMT 2023
PRIMARY
CAS
1310693-92-5
Created by admin on Sat Dec 16 13:25:39 GMT 2023 , Edited by admin on Sat Dec 16 13:25:39 GMT 2023
PRIMARY
FDA UNII
UHCM2AYJVX
Created by admin on Sat Dec 16 13:25:39 GMT 2023 , Edited by admin on Sat Dec 16 13:25:39 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
TARGET -> INHIBITOR
Tubastatin A HCl is a potent and selective HDAC6 inhibitor in a cell-free assay.
INHIBITOR
IC50